The goal of this clinical trial is to investigate whether intravenous injection of tilofiban can reduce microembolism in patients with unruptured intracranial aneurysms after Stent-Assisted Coil Embolization.The main questions it aims to answer are: * Is it safe to inject tirofiban intravenously during interventional treatment of intracranial aneurysms? * What dose of tirofiban is safe and effective?
We aim to reduce microembolism in patients with unruptured intracranial aneurysms after Stent-Assisted Coil Embolization.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
70
Intravenous administration of tirofiban
Intravenous administration of normal saline
Jiangsu Province Hospital
Nanjing, China
RECRUITINGMicroembolism
Number of microembolism
Time frame: Within 72 hours after surgery
The incidence of microembolism
The incidence of microembolism
Time frame: Within 48 hours after surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.